Cecilia Cotta-Ramusino has 25 years of experience in academia and industry, with pioneering work in DNA damage, genomics, and gene editing. Cecilia was an early scientist at Editas, shaping its CRISPR platform, then joined insitro as Head of Functional Genomics. Since 2019, she has led platform development at Tessera Therapeutics as SVP, driving innovation in gene editing inspired by mobile genetic elements.